MiR-181c suppresses triple-negative breast cancer tumorigenesis by targeting MAP4K4
D Xie, S Li, T Wu, X Wang, L Fang - Pathology-Research and Practice, 2022 - Elsevier
Breast cancer (BC) ranks as the highest incidence among cancer types in women all over
the world. Triple-negative breast cancer (TNBC) is known as a highly aggressive subtype of …
the world. Triple-negative breast cancer (TNBC) is known as a highly aggressive subtype of …
[HTML][HTML] MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24
Z Li, Q Meng, A Pan, X Wu, J Cui, Y Wang, L Li - Oncotarget, 2016 - pmc.ncbi.nlm.nih.gov
Lacking of treatment methods for the patients with triple negative breast cancer (TNBC)
underscores the pivotal needs to further understand its biology as well as to find better …
underscores the pivotal needs to further understand its biology as well as to find better …
[HTML][HTML] Tumor suppressor role of microRNA-1296 in triple-negative breast cancer
B Phan, S Majid, S Ursu, D de Semir, M Nosrati… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Triple negative breast cancer (TNBC) is an aggressive subtype of breast cancer with a poor
prognosis, which lacks effective targeted therapies. There is an urgent need to better …
prognosis, which lacks effective targeted therapies. There is an urgent need to better …
Molecular pathogenesis of triple-negative breast cancer based on microRNA expression signatures: antitumor miR-204-5p targets AP1S3
H Toda, S Kurozumi, Y Kijima, T Idichi… - Journal of human …, 2018 - nature.com
Triple-negative breast cancer (TNBC) is an aggressive type of cancer associated with a poor
prognosis. Identification of novel therapeutic targets in TNBC is urgently needed. Here, we …
prognosis. Identification of novel therapeutic targets in TNBC is urgently needed. Here, we …
[HTML][HTML] MicroRNA-941 regulates the proliferation of breast cancer cells by altering histone H3 Ser 10 phosphorylation
SK Surapaneni, ZR Bhat, K Tikoo - Scientific reports, 2020 - nature.com
Breast cancer including triple negative breast cancer (TNBC) represents an important
clinical challenge, as these tumours often develop resistance to conventional …
clinical challenge, as these tumours often develop resistance to conventional …
[HTML][HTML] MiR-4649-5p acts as a tumor-suppressive microRNA in triple negative breast cancer by direct interaction with PIP5K1C, thereby potentiating growth-inhibitory …
K Jonas, F Prinz, M Ferracin, K Krajina, B Pasculli… - Breast Cancer …, 2023 - Springer
Background Triple negative breast cancer (TNBC) is a particularly aggressive and difficult-to-
treat subtype of breast cancer that requires the development of novel therapeutic strategies …
treat subtype of breast cancer that requires the development of novel therapeutic strategies …
miR-518a-3p suppresses triple-negative breast cancer invasion and migration through regulation of TMEM2
L Gan, H Yang, Z Xiong, Z Yang… - Technology in Cancer …, 2020 - journals.sagepub.com
MicroRNAs (miRNAs) are emerging as critical mediators in tumors, including triple-negative
breast cancer (TNBC). The role of miR-518a-3p in TNBC was investigated to identify …
breast cancer (TNBC). The role of miR-518a-3p in TNBC was investigated to identify …
[HTML][HTML] MicroRNA‑589 serves as a tumor suppressor microRNA through directly targeting metastasis‑associated protein 2 in breast cancer
J Chu - Oncology letters, 2019 - spandidos-publications.com
Triple‑negative breast cancer (TNBC) has a poorer outcome compared with that of other
subtypes of breast cancer, and the discovery of dysregulated microRNA (miRNA) and their …
subtypes of breast cancer, and the discovery of dysregulated microRNA (miRNA) and their …
[HTML][HTML] Association of high miR-27a, miR-206, and miR-214 expression with poor patient prognosis and increased chemoresistance in triple-negative breast cancer
Y Liu, W Gong, K Panoutsopoulou… - American Journal of …, 2023 - ncbi.nlm.nih.gov
Triple-negative breast cancer (TNBC) represents the most aggressive breast cancer
subtype, associated with early metastasis and recurrence as well as poor patient outcome …
subtype, associated with early metastasis and recurrence as well as poor patient outcome …
miR-185 suppresses tumor proliferation by directly targeting E2F6 and DNMT1 and indirectly upregulating BRCA1 in triple-negative breast cancer
Breast cancer is a major public health problem all over the world, and the current treatment
strategies are not potent enough for some patients, especially those with triple-negative …
strategies are not potent enough for some patients, especially those with triple-negative …